Skip to main content
SpringerLink
Log in

Circulating interleukin-6 significantly correlates to thyroid hormone in acute myocardial infarction but not in chronic heart failure

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

To investigate relationships between thyroid states and the cardiac endocrine system, we analyzed thyrotropin (TSH), thyroid hormone, plasma levels of interleukin-6 (IL-6) and brain natriuretic peptide (BNP) in 50 patients with chronic heart failure (CHF), in 30 patients with heart failure from acute myocardial infarction (AMI), and in 15 controls. Plasma levels of IL-6 and BNP in both CHF and AMI were significantly elevated, while free triiodothyronine (FT3) was significantly decreased compared to controls. FT3/ free thyroxine (FT4) ratio was significantly decreased in CHF but not in AMI compared to controls. In CHF, diuretic treatment diminished circulating BNP but not IL-6, while diuretic treatment increased FT3/FT4 ratio. In AMI, FT3/ FT4 ratio was significantly decreased 72h compared to 12h after the onset of AMI, while BNP and IL-6 were significantly increased 72h compared to 12h after the onset of AMI. In both CHF and AMI, BNP significantly correlated with FT4. On the other hand, significant correlations between IL-6 and FT3, and between IL-6 and FT3/FT4 ratio were detected in AMI but not in CHF. This preliminary study suggests that IL-6, BNP and thyroid hormone reflect ventricular dysfunction in both acute and chronic heart failure, and that IL-6 significantly relates to circulating thyroid hormone in AMI but not in CHF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wartofsky L., Burman K.D. Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr. Rev. 1982, 3: 164–217.

    Article  CAS  PubMed  Google Scholar 

  2. De Groot L.J. Dangerous dogmas in medicine: The nonthyroidal illness syndrome. J. Clin. Endocrinol. Metab. 1999, 84: 151–164.

    Article  PubMed  Google Scholar 

  3. Kimura T., Kanda T., Kuwabara A., Shinohara H., Kobayashi I. Participation of the pituitary-thyroid axis in the cardiovascular system in elderly patients with congestive heart failure. J. Med. 1997, 28: 75–80.

    CAS  PubMed  Google Scholar 

  4. Boelen A., Schiphorst M.C.P., Wiersinga W.M. Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J. Clin. Endocrinol. Metab. 1993, 77: 1695–1699.

    CAS  PubMed  Google Scholar 

  5. Boelen A., Maas M.A.W., Lowik C.W.G.M., Platvoet M.C., Wiersinga W.M. Induced illness in interleukin-6 (IL-6) knock-out mice: A causal role of IL-6 in the development of the low 3,5,3′-triiodothyronine syndrome. Endocrinology 1996, 137: 5250–5254.

    CAS  PubMed  Google Scholar 

  6. Hashimoto H., Igarashi N., Yachie A., Miyazaki T., Sato T. The relationship between serum levels of interleukin-6 and thyroid hormone in children with acute respiratory infection. J. Clin. Endocrinol. Metab. 1994, 78: 288–291.

    CAS  PubMed  Google Scholar 

  7. Bartalena L., Brogioni S., Grasso L., Velluzzi F., Martino E. Relationship of the increased interleukin-6 concentration to changes of thyroid function in nonthyroidal illness. J. Endocrinol. Invest. 1994, 17: 269–274.

    CAS  PubMed  Google Scholar 

  8. Van Haasteren G.A.C., van der Meer M.J.M., Hermus A.R.M.M., Linkels E., Klootwijk W., Kaptein E., Van Toor H., Sweep G.C.J. Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysialthyroid axis. Endocrinology 1994, 135: 1336–1345.

    PubMed  Google Scholar 

  9. Boelen A., Schiphorst M.C.P., Wiersinga W.M. Soluble cytokine receptors and the low 3,5,3′-triiodothyronine syndrome in patients with nonthyroidal disease. J. Clin. Endocrinol. Metab. 1995, 80: 971–976.

    CAS  PubMed  Google Scholar 

  10. Hashimoto H., Igarashi N., Yachie A., Miyawaki T., Hashimoto T., Sato T. The relationship between serum levels of interleukin- 6 and thyroid hormone during the follow-up study in children with nonthyroidal illness: marked inverse correlation in Kawasaki and infectious disease. Endocr. J. 1996, 43: 31–38.

    Article  CAS  PubMed  Google Scholar 

  11. Davies P.H., Black E.G., Sheppard M.C., Franklyn J.A. Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with nonthyroidal illness. Clin. Endocrinol. (Oxf.) 1996, 44: 199–205.

    Article  CAS  Google Scholar 

  12. Levine B., Kalman J., Mayer L., Fillit H., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 1990, 323: 236–241.

    Article  CAS  PubMed  Google Scholar 

  13. Torre-Amione G., Kapadia S., Lee J., Bies R., Lebovitz R., Mann D. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995, 92: 1487–1493.

    Article  CAS  PubMed  Google Scholar 

  14. Torre-Amione G., Kapadia S., Lee J., Durand J.B., Bies R., Young J., Mann D. Tumor necrosis factor-alfa and tumor necrosis factor receptors in the failing human heart. Circulation 1996, 93: 704–711.

    Article  CAS  PubMed  Google Scholar 

  15. Munger M., Johnson B., Amber I., Callahan K., Gilbert E. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or IDC. Am. J. Cardiol. 1996, 77: 723–727.

    Article  CAS  PubMed  Google Scholar 

  16. Lommi J., Pulkkit K., Koshinen P., Naveri H., Leinonen H., Harkonen M., Kupari M. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur. Heart J. 1997, 18: 1620–1625.

    Article  CAS  PubMed  Google Scholar 

  17. Niebauer J., Volk H.D., Kemp M., Dominguez M., Schumann R.R., Rauchhaus M., Poole-Wilson P.A., Coats A.J.S., Anker S.D. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999, 353: 1838–1842.

    Article  CAS  PubMed  Google Scholar 

  18. Hamilton M.A., Stevenson L.W., Luu F.M., Walden J.A. Altered thyroid hormone metabolism in advanced heart failure. J. Am. Coll. Cardiol. 1990, 16: 91–95.

    Article  CAS  PubMed  Google Scholar 

  19. Nakao K, Mukoyama M., Hosoda K., Suga S., Ogawa Y., Saito Y., Shirakami G., Arai H., Jougasaki M., Imura H. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide. Can. J. Physiol. Pharmacol. 1991, 69: 1500–1506.

    Article  CAS  PubMed  Google Scholar 

  20. Mukoyama M., Nakao K., Hosoda K., Suga S., Saito Y., Ogawa Y., Shirakami G., Jougasaki M., Obata K., Yasue H., Kambayashi Y., Inouye K., Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest. 1991, 87: 1402–1412.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Arakawa N., Nakamura M., Aoki H., Moriai N., Suzuki T., Hiramori K. Prognostic value of plasma brain natriuretic peptide concentration in patients with acute myocardial infarction. Circulation 1994, 90: I–279. Abstract.

    Google Scholar 

  22. Omland T., Aakvaag A., Bonarjee V.V.S., Caidahl K., Lie R.T., Nilsen D.W.T., Sundsfjord J.A., Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996, 93: 1963–1969.

    Article  CAS  PubMed  Google Scholar 

  23. Kohno M., Horio T., Yasunari K., Ikeda M., Kurihara N., Nishizawa Y., Morii H., Takeda T. Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. Metabolism 1993, 42: 1059–1064.

    Article  CAS  PubMed  Google Scholar 

  24. Ikeda U., Ohkawa F., Seino Y., Yamamoto K., Hidaka Y., Kasahara T., Kawai T., Shimada K. Serum lnterleukin-6 becomes elevated in acute myocardial infarction. J. Mol. Cell. Cardiol. 1992, 24: 579–584.

    Article  CAS  PubMed  Google Scholar 

  25. Guillen I., Blanes M., Gomez-Lechon M.J., Castell J.V. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am. J. Physiol. 1995, 269: 229–235.

    Google Scholar 

  26. Neumann F.J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., Schoeming A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995, 92: 748–755.

    Article  CAS  PubMed  Google Scholar 

  27. Gwechenberger M., Mendoza L.H., Youker K.A., Frangogiannis N.G., Smith W., Michael L.H., Entman M.L. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999, 99: 546–551.

    Article  CAS  PubMed  Google Scholar 

  28. Bysani C., Mitchell D.H., Colston J.T., Freeman G.L. Regulation of CCAAT/enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ische-mia/reperfusion. Circulation 1999, 99: 427–433.

    Article  Google Scholar 

  29. Roig E., Orus J., Pare C., Azqueta M., Filella X., Perez-Villa F., Heras M., Sanz G. Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am. J. Cardiol. 1998, 82: 688–690.

    Article  CAS  PubMed  Google Scholar 

  30. Ingbar S.H., Woeber K.A. Textbook of Endocrinology. Saunders, Philadelphia, PA, 1992, pp. 157–162, 191–199.

    Google Scholar 

  31. Morita E., Yasue H., Yoshimura M., Ogawa H., Jougasaki M., Matsumura T., Mukoyama M., Nakao K. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993, 88: 82–91.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine, Gunma University School of Medicine, 3-39-15 Showa-machi, Maebashi, 371-8511, Japan

    M. Nishino, T. Kimura, T. Kanda M.D., N. Kotajima, A. Yoshida, A. Kuwabara, K. Tamama, Y. Fukumura & I. Kobayashi

Authors
  1. M. Nishino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Kanda M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Kotajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Kuwabara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Tamama
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Y. Fukumura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. I. Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Kanda M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishino, M., Kimura, T., Kanda, T. et al. Circulating interleukin-6 significantly correlates to thyroid hormone in acute myocardial infarction but not in chronic heart failure. J Endocrinol Invest 23, 509–514 (2000). https://doi.org/10.1007/BF03343766

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343766

Key-words

Search

Navigation